Par Pharmaceuticals agrees $100m patent settlement

Managing IP Correspondent

September 23 2014

Par Pharmaceuticals has agreed to pay $100 million to a unit of Salix Pharmaceuticals and the University of Missouri to settle a lawsuit alleging it had infringed two patents related to the heartburn drug Zegerid

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Request Access or Login

Topics

News Patents North America Jurisdictions United States (National)

Managing IP Correspondent

more from across site and SHARED ros bottom lb

More from across our site

Patents

Judge,Gavel,,Stethoscope,,And,Medicine,Tablets,In,Blister,Packs,On

The UPC and life sciences three years in: medtech’s early success, pharma/biotech’s selective bet

McDermott Will & Schulte lawyers explore why the UPC is seeing rapid adoption by medtech for fast-moving disputes, while pharma and biotech take a cautious, selective approach over revocation risks

Charles Larsen, September 29 2026

Patents

Wooden,Peg,Dolls,With,Question,Marks,Looking,At,Coin,Stacks

Beyond the headlines: PE isn’t the problem. The exit might be

IP firms may be growing more comfortable with external capital, but uncertainty over who could ultimately own the business is complicating the investment pitch

Sukanya Sarkar, September 29 2026

Patents

The IP Lounge: From Texas trials to marathon miles with Alan Albright

The former Western District of Texas judge addresses perceptions of his courtroom, reveals what comes next as he returns to practice at A&O Shearman and explains why marathon running is ‘cathartic’

Sanjana Mishra, September 29 2026

Trademarks

Beautiful,Aerial,View,Of,Downtown,Vancouver,Skyline,,British,Columbia,,Canada

Row erupts over INTA 2028 Annual Meeting in Vancouver

International Anti-Counterfeiting Coalition says it has been blocked from hosting its annual event in the city, ending a long tradition of holding the gathering in the days leading up to INTA’s flagship event

Max Walters, September 28 2026

Patents

‘Wide net, big hammer’: ITC proves popular for data centre litigation

The ITC is a powerful tool for litigators, practitioners say, as the threat of an exclusion order on a critical tech component could mean disrupting the entire data centre's operations

Sanjana Mishra, September 28 2026

Trademarks

Exclusive: Rajah & Tann hires Amica Law TM veteran

Anna Toh plans to expand Rajah & Tann’s soft IP capabilities, leveraging its Southeast Asia network to support clients on cross-border portfolio management and commercial strategy

Sukanya Sarkar, September 28 2026

Patents

Pulse Law bets on tech-powered IP model

The Canadian boutique’s new IP lead says he wants to build a tech-enabled IP practice aimed at giving startups senior expertise away from the traditional ‘big law’ set-up

Sanjana Mishra, September 25 2026

Patents

Weekly take: The PE debate in IP may already be settled

Qantm IP’s acquisition of Henry Goh & Co shows shifting attitudes towards private equity, with firms increasingly viewing external backing as a normal route to expansion rather than a source of concern

Sukanya Sarkar, September 25 2026

Boies Schiller deepens AI bench as firms compete for specialist talent

The firm’s involvement in prominent AI cases drew litigator Christian Mammen to join from Womble Bond Dickinson, as US firms continue to bolster AI-focused practices

Sanjana Mishra, September 24 2026

Patents

Earth,At,Night,With,Colorful,Digital,Lines,Representing,Global,Communication,

UPC update: New judges inducted | firms test pan-European limits

Two judicial appointments confirmed in Paris and Mannheim, while cross-border injunctions and high-profile procedural rulings keep major patent practices occupied

September 24 2026